Jianji™
Diagnostics Intelligence Platform
Jianji™ supports observational analysis related to biomarker testing adoption, reimbursement dynamics, and laboratory activity across precision medicine markets.
Biomarker Activity Across Precision Oncology
- PD-L1
- HER2-low
- EGFR
- ALK
- CLDN18.2
- ROS1
- DLL3
- MSI/MMR
- RET
- DLBCL COO
- TMB
- BCR-ABL1
- FLT3
- PIK3CA
- IDH1/2
Built around real-world diagnostics adoption.